Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Health experiences of pregnant and women with chagas disease in the Atacama, Tarapaca, and Metropolitan regions of Chile. Mistreatment as an indicator of healthcare barriers

Avaria A, Plaza C, Saraiva RM. Public Library of Science (PLoS). PLOS ONE. 2024; 19 (11) : 1-14.
Download PDF
Publication

Chagas Disease and Maternal Mortality: An Overlooked Link in a Neglected Disease in Brazil

Rivera MAM, Rivera IR, Oliveira GMMD, et al. Sociedade Brasileira de Cardiologia. International Journal of Cardiovascular Sciences. 2024;
Download PDF
Publication

Changes in lipid abundance are associated with disease progression and treatment response in chronic Trypanosoma cruzi infection

Gabaldón-Figueira JC, Ros-Lucas A, Martínez-Peinado N, et al. Springer Science and Business Media LLC. Parasites & Vectors. 2024; 17 (1) : 1-14.
Download PDF
Publication

Spatio-temporal trends in mortality due to Chagas disease in the State of Bahia, Brazil, from 2008 to 2018

Carvalho CMMD, Ribeiro-Jr G, Gurgel-Gonçalves R, et al. FapUNIFESP (SciELO). Revista da Sociedade Brasileira de Medicina Tropical. 2024;
Download PDF
Publication

Doenças Negligenciadas na Região Sul do Ceará: Um Desafio Persistente no Nordeste Brasileiro

Lima AG, Beserra AT, Jerônimo GAC, et al. Brazilian Journals. Brazilian Journal of Biological Sciences. 2024; 11 (25) : 1-9.
Download PDF
Publication

Drugs for Vector-Borne Protozoal Diseases in a One Health Scenario. A European Perspective

Cordeiro da Silva A, Calogeropoulou T, Costi MP, et al. American Chemical Society (ACS). ACS Infectious Diseases. 2024;
Download PDF
Publication

The Impact of Environmental and Housing Factors on the Distribution of Triatominae (Hemiptera, Reduviidae) in an Endemic Area of Chagas Disease in Puebla, Mexico.

Ortega-Caballero M, Gonzalez-Vazquez M, Hernández-Espinosa M, et al. Diseases (Basel, Switzerland). 2024; 12 (10) : 1-11.
Download PDF
Publication

Policy and Executive Barriers in Preventing and Eradicating Neglected Tropical Diseases: A Systematic Review

Sarabi Asiabar A, Jabbari A, Rezapour A, et al. International Journal of Preventive Medicine. 2024;
Download PDF
Publication

Neglected Tropical Disease (NTDs)

Bates S, Peirce J, Biju A. Springer Nature Switzerland. A Healthcare Students Introduction to Global Health. 2024;
Publication

The crucial role of drug repositioning in tackling Chagas disease, sleeping sickness, and leishmaniasis

O. J. Porta E. INNOSC Theranostics and Pharmacological Sciences. 2024;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 7
  • Next page ››
Subscribe to Chagas disease (American trypanosomiasis)

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD